A SVP CORPORATE STRATEGY Of Teladoc Health Inc. (TDOC) Sells 1000.0 Shares

0
7
KOSK
KOSK

Teladoc Health Inc. (NYSE:TDOC) saw a downside of -1.66% to close Tuesday at $27.20 after subtracting -$0.46 on the day. The 5-day average trading volume is 4,656,840 shares of the company’s common stock. It has gained $31.45 in the past week and touched a new high 2 times within the past 5 days. An average of 4,570,255 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,453,958.

TDOC’s 1-month performance is 2.76% or $3.67 on its low of $21.60 reached on 01/06/23. The company’s shares have touched a 52-week low of $21.60 and high of $80.83, with the stock’s rally to the 52-week high happening on 01/24/23. YTD, TDOC has achieved 15.01% or $3.55 and has reached a new high 7 times. However, the current price is down -66.35% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Insider Transactions

TDOC stock investors last saw insider trading activity on Jan 17.Trencher Daniel (SVP CORPORATE STRATEGY) most recently sold 1,000 shares at $26.80 per share on Jan 17. This transaction cost the insider $26,800. SVP CORPORATE STRATEGY, Trencher Daniel, sold 1,000 shares at a price of $26.93 on Dec 19. Then, on Dec 01, CHIEF INNOVATION OFFICER Jensen Claus Torp sold 1,783 shares at a price of $28.86 per share. This transaction amounted to $51,457.

Valuation Metrics

TDOC stock has a beta of 0.98. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.81 while the price-to-book (PB) in the most recent quarter is 0.73, with the price to cash flow ratio at 21.64.

Teladoc Health Inc.’s quick ratio for the period ended September 29 was 3.00, with the current ratio over the same period at 3.10. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.25, while the total debt to equity was 0.26.. In terms of profitability, the gross margin trailing 12 months is 68.60%. The firm’s gross profit as reported stood at $1.38 billion against revenue of $2.03 billion.

Earnings Surprise

For the quarterly period ending September 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -82.12% to -$73.48 million, while revenue of -$3.1 billion was -4120.82% off the previous quarter. Analysts expected TDOC to announce -$0.57 per share in earnings in its latest quarter, but it posted -$0.45, representing a 21.10% surprise. EBITDA for the quarter stood at more than -$5.46 million. TDOC stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 2.05 billion, with total debt at $1.61 billion. Shareholders hold equity totaling $161.93 million.

Let’s look briefly at Teladoc Health Inc. (TDOC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 58.74% to suggest the stock is trending Neutral, with historical volatility in this time period at 72.14%.

The stock’s 5-day moving average is $26.47, reflecting a -3.61% or -$1.02 change from its current price. TDOC is currently trading +12.35% above its 20-day SMA, -12.57% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +1.64% and SMA200 by-59.82%.

Stochastic %K and %D was 68.55% and 64.25% and the average true range (ATR) pointed at 1.92. The RSI (14) points at 55.80%, while the 14-day stochastic is at 56.85% with the period’s ATR at 1.78. The stock’s 9-day MACD Oscillator is pointing at 0.48 and 1.73 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Teladoc Health Inc. (NYSE: TDOC), Guggenheim upgraded it to a Neutral rating. They previously had a Sell rating on the stock. Analysts offering their rating for TDOC stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate TDOC as a “sell,”, while 25 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 5 have offered a “buy” rating.

What is TDOC’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $24.00 and a high of $40.00, with their median price target at $31.00. Looking at these predictions, the average price target given by analysts is for Teladoc Health Inc. (TDOC) stock is $31.78.

LEAVE A REPLY

Please enter your comment!
Please enter your name here